Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 358 citing articles:

Long-term Quality of Life and Functional Outcome of Patients With Rectal Cancer Following a Watch-and-Wait Approach
Petra A. Custers, Marit E. van der Sande, Brechtje A. Grotenhuis, et al.
JAMA Surgery (2023) Vol. 158, Iss. 5, pp. e230146-e230146
Open Access | Times Cited: 48
Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis
Inesa Bunevičienė, Rania A. Mekary, Timothy R. Smith, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103123-103123
Open Access | Times Cited: 84
Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomised Controlled Trial
Riccardo Mastroianni, Gabriele Tuderti, Umberto Anceschi, et al.
European Urology Focus (2021) Vol. 8, Iss. 2, pp. 465-471
Open Access | Times Cited: 67
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Mahmoud Elsawy, Julio C. Chávez, Irit Avivi, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2248-2260
Open Access | Times Cited: 44
Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]
Barbara Jarząb, Marek Dedecjus, Andrzej Lewiński, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 2, pp. 173-300
Open Access | Times Cited: 40
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
Michel Delforge, Krina K. Patel, Laurie Eliason, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 3, pp. e216-e227
Closed Access | Times Cited: 12
Long‐term health‐related quality of life in head and neck cancer survivors: A large multinational study
Kathy Taylor, Cecilie Delphin Amdal, Kristin Bjordal, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 10, pp. 1772-1785
Open Access | Times Cited: 11
Sarcopenic Obesity and Outcomes for Patients With Cancer
Chenan Liu, Tong Liu, Li Deng, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2417115-e2417115
Open Access | Times Cited: 8
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
Meletios A. Dimopoulos, Peter M. Voorhees, Fredrik Schjesvold, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 8
Quality of Life and Social Health in Patients After Pancreatic Surgery
Nicholas Galouzis, Maria Khawam, Evelyn V. Alexander, et al.
Journal of Gastrointestinal Surgery (2025), pp. 101969-101969
Closed Access | Times Cited: 1
Understanding quality of life in Danish women with metastatic breast cancer undergoing multiple treatments
Helle Pappot, Anne Jørgensen, Anna Hincheli Bjørum, et al.
Acta Oncologica (2025) Vol. 64, pp. 292-302
Open Access | Times Cited: 1
Health-related quality of life in Singapore: Population norms for the EQ-5D-5L and EORTC QLQ-C30
Jaclyn Tan, Mervyn Jun Rui Lim, Ravindran Kanesvaran, et al.
Annals of the Academy of Medicine Singapore (2025) Vol. 54, Iss. 3, pp. 147-149
Open Access | Times Cited: 1
Effect of enhanced recovery after radiotherapy (ERAR) on the quality of life in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial
Nan Lin, Xueyan Zhou, Yusha Wang, et al.
Oral Oncology (2025) Vol. 164, pp. 107269-107269
Closed Access | Times Cited: 1
Quality of life in patients with cancer during the COVID-19 pandemic – a Danish cross-sectional study (COPICADS)
Stefan Starup Jeppesen, Kristian Kirkelund Bentsen, Trine Lembrecht Jørgensen, et al.
Acta Oncologica (2020) Vol. 60, Iss. 1, pp. 4-12
Open Access | Times Cited: 60
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic
Eugenie Younger, Alannah Smrke, Emma Lidington, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2288-2288
Open Access | Times Cited: 58
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer
Justyna Mierzynska, Mekdes Taye, Madeline Pe, et al.
European Journal of Cancer (2019) Vol. 125, pp. 69-82
Open Access | Times Cited: 56
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Matthias Preusser, Antonio Silvani, Émilie Le Rhun, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 755-767
Open Access | Times Cited: 55
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial
Andrew Bottomley, Corneel Coens, Justyna Mierzynska, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 5, pp. 655-664
Open Access | Times Cited: 55
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)
Nadia Harbeck, Fábio Franke, Rafael Villanueva-Vázquez, et al.
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 52
Sex-differences in symptoms and functioning in >5000 cancer survivors: Results from the PROFILES registry
Sabine Oertelt‐Prigione, Belle H. de Rooij, Floortje Mols, et al.
European Journal of Cancer (2021) Vol. 156, pp. 24-34
Open Access | Times Cited: 49
Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
Michel Delforge, Nina Shah, Jesús F. San Miguel, et al.
Blood Advances (2021) Vol. 6, Iss. 4, pp. 1309-1318
Open Access | Times Cited: 49
Prevalence and correlates of cancer-related fatigue in breast cancer survivors
Alejandro Álvarez‐Bustos, Cristina G. de Pedro, María Romero-Elías, et al.
Supportive Care in Cancer (2021) Vol. 29, Iss. 11, pp. 6523-6534
Closed Access | Times Cited: 43
General population normative data for the EQ-5D-3L in the five largest European economies
Mathieu F. Janssen, A. Simon Pickard, James W. Shaw
The European Journal of Health Economics (2021) Vol. 22, Iss. 9, pp. 1467-1475
Open Access | Times Cited: 42
Experiences of breast cancer survivors during the COVID-19 pandemic: a qualitative study
Memnun Seven, Gülcan Bağçıvan, Şeyma İnciser Paşalak, et al.
Supportive Care in Cancer (2021) Vol. 29, Iss. 11, pp. 6481-6493
Open Access | Times Cited: 41
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
Matilda Appelgren, Helena Sackey, Yvonne Wengström, et al.
The Breast (2022) Vol. 63, pp. 16-23
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top